According to researchers, COVID-19 patients struggling with severe neurological symptoms exhibit signs of impairment in the blood-brain barrier, and changes in brain structure depending on the severity of their symptoms.
Through a new study, researchers have developed a pseudovirus system that can quantify the ability of one s antibodies to neutralize the SARS-CoV-2 virus and its variants.
The new multi-institutional study is among the first large-scale studies to compare the outcomes of the COVID-19 infection caused by Omicron to that brought on by Delta in children below the age of five.